MTOR and acute myeloid leukemia: We also observed decreased phosphorylation at these phosphosites (AKT S473, mTOR S2448, and ULK1 S757) in a primary FLT3-ITD + AML sample treated ex vivo with FLT3i (Supplementary Fig. 8).